April 3rd 2025
The study stated early recognition and aggressive treatment of childhood-onset MMP are essential to prevent permanent scarring.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
HPV vaccine approval will lead to several questions
June 1st 2006Washington - A human papilloma virus (HPV) vaccine, based onnoninfectious virus-like particles, could be on the market as earlyas this summer, according to John Schiller, Ph.D., section chief,laboratory of cellular oncology, National Cancer Institute,Bethesda, Md.
Laser, light treatments expanding, combining modalities
June 1st 2006Key developments from the recent American Society for Laser Medicine and Surgery (ASLMS) meeting include broader applications for existing devices and the growing availability of treatments that combine modalities, sources tell Dermatology Times.
Biafine offers innovative wound healing solution
May 1st 2006Las Vegas - The new wound healing product Biafine (OrthoNeutrogena), gaining popularity among radiation oncologists for the treatment of radiation dermatitis, also offers an innovative option for dermatologists in treating problems ranging from sunburn to superficial wounds, according to Diane Berson, M.D., speaking at the annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery here.
Vascular birthmarks: Causes for concern, reasons for hope
May 1st 2006National report - Vascular birthmarks in the pediatricpopulation can create a wide array of questions and concerns forphysicians and parents, says Ilona Frieden, M.D., of the departmentof dermatology, University of California, San Francisco.
Progress continues in treating pediatric skin ailments
April 1st 2006National report ? While topical calcineurin inhibitors for treating atopic dermatitis (AD) continue to grab headlines, sources tell Dermatology Times that research into additional treatments for pediatric skin problems is progressing.